The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

solvaypharmaceuticals.com

Stage

Acquired | Acquired

About Solvay Pharmaceuticals

Solvay Pharmaceuticals is a research driven group of companies that constitutes the global pharmaceutical business of the Solvay Group. The company seeks to fulfill selected, unmet medical needs in the therapeutic areas of neuroscience, cardiometabolic, influenza vaccines, gastroenterology and men's and women's health.In September 2009, Solvay Pharmaceuticals was acquired by Abbott Labs. The valuation of Solvay Pharmaceuticals was undisclosed. Other terms of the deal were not released.

Solvay Pharmaceuticals Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Solvay Pharmaceuticals Patents

Solvay Pharmaceuticals has filed 19 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/2/2008

6/4/2013

Actinomycetales, Diabetes, Enzymes, Protein domains, Inflammations

Grant

Application Date

12/2/2008

Grant Date

6/4/2013

Title

Related Topics

Actinomycetales, Diabetes, Enzymes, Protein domains, Inflammations

Status

Grant

Latest Solvay Pharmaceuticals News

Cannabis Pharmaceutical Market Is Expected To Witness Faster Growth During The Forecast Period 2021-2030 In Asia Pacific - Report By Acumen Research And Consulting

Apr 13, 2021

April 13, 2021 13:04 ET Pune, INDIA Acumen Research and Consulting, a global provider of market research studies, recently added a forthcoming report titled “Cannabis Pharmaceutical Market - Global Industry Analysis, Market Size, Opportunities and Forecast 2021 - 2030” gives insights about the rapidly progressing Cannabis Pharma Market LOS ANGELES, April 13, 2021 (GLOBE NEWSWIRE) -- The rapidly progressing transformation of cannabis from herbal preparations to prescription drugs is contributing to the market growth. The increasing use of cannabis-based pharmaceuticals for multiple indications including chronic pain, epilepsy, inflammation, sleep disorders, schizophrenia, anorexia, and symptoms of multiple sclerosis is driving the market growth. Additionally, some of the pharmaceutical drugs based on cannabis include Sativex (GW Pharmaceuticals), Epidiolex, Dronabinol/Marinol (Unimed Pharmaceuticals), Nabilone/Cesamet (Valeant Pharmaceuticals International), Dexanabinol (Solvay Pharmaceuticals), CT-3 (ajulemic acid) (Indevus Pharmaceuticals), Cannabinor (formerly PRS-211,375) (Pharmos), HU 308 (Pharmos), HU 331(Cayman Chemical), Rimonabant/Acomplia (Sanofi-Aventis), and Taranabant / MK-0364 (Merck). DOWNLOAD SAMPLE PAGES OF THIS REPORT@ https://www.acumenresearchandconsulting.com/request-sample/2560 Market Segmentation The global cannabis pharmaceutical market is segmented on the basis of product type, application, distribution channel, and geography. Based on product type, the market is segmented on the basis of solids, dissolvable/powders, oil, and ointments & creams. The cannabis pharmaceuticals find application across cancer, arthritis, migraine, epilepsy, and others. Based on the distribution channel, the market is bifurcated into hospital pharmacies, online pharmacies, and retail pharmacies. Based on geography, the market is bifurcated into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The aforementioned regions are also further bifurcated into major countries of the respective region Ointments or creams Medicated ointment or balms work by consolidating cannabis with other skin-soothening ingredients, which is scoured into your skin to help soothe muscle torment. There are many ointments that are accessible in different flavors like cedar wood and orange, or lavender and bergamot. They utilize a blend of molding fixings and cannabis concentrate to relieve both dry skin and muscle hurts. VIEW TABLE OF CONTENT OF THIS REPORT@ https://www.acumenresearchandconsulting.com/cannabis-pharmaceutical-market Market By Product: Oil CBD is removed from marijuana plants as either an oil or powder. These can be blended into creams or gels. They can be placed into capsules and taken orally, or scoured on your skin. The numerous sclerosis drug nabiximols is showered as a fluid into your mouth. How CBD ought to be utilized relies to a great extent upon what it's being utilized for. Unlike with PCP prior to utilizing CBD oil. It hasn't been affirmed by the U.S. Food and Drug Administration (FDA) for any clinical uses, and it can have results. Market By Product: Dissolvable powders Dissolvable cannabinoid powders have an unending number of uses, making it perhaps the most adaptable cannabis-imbued items accessible available today. Given their water dissolvability and the way that they are completely enacted, they become more bioavailable when devoured. This implies that buyers will encounter the impacts quicker, longer, and all the more effectively. Market By Product: Solid CBD isolate is a translucent solid or powder involving unadulterated CBD. It is not quite the same as full-range CBD items, which can legitimately contain up to 0.3%Trusted Source THC. This amount may appear on a medication test; however, it won't cause a high. To deliver CBD solid, makers utilize different cycles to extricate every one of the mixtures and different substances from the cannabis plant, including THC. The process leaves unadulterated CBD in crystal form. Manufacturers may then granulate the crystals into a powder to make the item simpler to devour. CBD separate doesn't have a particular smell or taste. Segment Analysis by Region North America held the major share (%) of the cannabis pharmaceuticals market. The rising prevalence of diseases like Alzheimer's disease and cancer is supporting regional market growth. The presence of major players in the region is further bolstering the regional market value. The major economies of the region including US and Canada are major contributors to the regional market value. The region is followed by Europe due to rising awareness about cannabidiol infused products in the region. Furthermore, Asia Pacific is projected to experience the fastest growth throughout the forecast period from 2020 to 2027. The increasing awareness about the medical benefits of cannabis, including its healing properties is propelling its demand in the Asia Pacific region. Many of the Asian countries are softening their perception towards cannabis is the positive factor projected to increase the market opportunities over the forecast period in the region. Browse Upcoming Market Research Reports@  https://www.acumenresearchandconsulting.com/forthcoming-reports Competitive Landscape Some of the leading competitors are Abbott Laboratories (Solvay Pharmaceuticals) (US), AbbVie Inc.(US), Cardiol Therapeutics (Canada), Cayman Chemical (US), Cure Pharmaceutical (US), GW Pharmaceuticals (UK), Indevus Pharmaceuticals (US), Insys Therapeutics, Inc. (US), Merck (Germany), Pharmos (US), Sanofi-Aventis, Solvay Pharmaceuticals (Abbott) (US), Tilray (Canada), Unimed Pharmaceuticals, Bausch Health (formerly Valeant Pharmaceuticals (Canada), and Zynerba Pharmaceuticals, Inc (US). Cannabis Pharmaceuticals companies have announced mergers and acquisitions, partnerships and collaborations, and new product development to expand their position in the Cannabis Pharmaceuticals industry. Major players are also moving into new regions with advanced technologies for gaining a competitive advantage. INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/2560 BUY THIS PREMIUM RESEARCH REPORT - https://www.acumenresearchandconsulting.com/buy-now/0/2560 Would like to place an order or any question, please feel free to contact at  sales@acumenresearchandconsulting.com  | +1 407 915 4157 For Latest Update Follow Us:

  • What is Solvay Pharmaceuticals's latest funding round?

    Solvay Pharmaceuticals's latest funding round is Acquired.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.